Deadline for submission: 11:59pm on Saturday, 4th July 2026 Central European Time (GMT/UHC +1)
Overview
Vaccine R&D Roadmaps produced by the World Health Organization (WHO) aim to provide a strategic framework outlining priority activities for global stakeholders, including vaccine researchers, funders, product sponsors, industry, regulatory authorities, policy-makers and the public. The Roadmap encourages innovation, facilitates progress and an acceleration of the pathway to vaccine licensure and policy recommendation, affordable availability, access and use in context of a functional delivery program, to ultimately address priority global health needs.
WHO vaccine R&D Roadmaps complement vaccine preferred product characteristics (PPCs) published by the WHO, which describe preferred parameters pertaining to key vaccine parameters. WHO vaccine R&D Roadmaps capture priorities at a certain moment in time and are intended to be updated as new evidence emerges and perspectives evolve. A first WHO Strep A Vaccine Development Technology Roadmap was developed and published in 2018, along with the expression of WHO Strep A Vaccine PPC. This updated R&D Roadmap provides a renewed vision and strategic goals for Strep A vaccine development, building on the 2018 identified priorities, updated according to evolutions in the field. Relative to the previous Roadmap, this version aimed to be broader in coverage, providing an end-to-end vaccine development perspective, informing stakeholders with more granularity, expressing needs with more details. It is neither product- nor product-type specific.
The current document has been produced by WHO Product & Delivery Research Unit, together with a small expert writing group, informed by consensus-building consultative process including a wide diversity of stakeholders. Of note, R&D Roadmaps are not WHO guidelines or formally linked to any of the policy recommendation and prequalification processes, but aim to promote preparation of such decisions and processes.
Objective of the consultation
The goal of this online, open public consultation is to gather feedback from stakeholders on the draft WHO Strep A Vaccine Research and Development Roadmap.
Please provide comments on the draft using the comment form posted on this webpage. Comments are invited in particular on overall clarity, usability, and any gaps in vaccine R&D pathway considerations developed in the document. You may provide feedback either for the entire document or only parts of it.
Comments may be publicly disclosed at a later stage of the review process; submission of comments will be considered as permission to publicly disclose the comment form. Submissions cannot be made anonymously. In order to make a submission, you will be required to provide valid responses to questions that ask your full name, your organizational affiliation (if any), your role (job title), your country of residence, your personal email address OR your organizational email address (if submitting on behalf of an organization). Submissions that are not accompanied by valid responses to these questions may not be accepted for consideration. We will not reveal any individual participants’ information or affiliations. We do not intend to publish the ‘raw information’ from the individual responses. Comments may be submitted by individuals or organizations, and can be submitted in English or French.
By participating, you consent to providing your personal information and comments to the WHO to contact you, if needed.
Please download the feedback form "StrepARMFB" and email it to vaccines@who.int with the subject line “Comments on draft Strep A Vaccine Research and Development Roadmap” by no later than Saturday, 4th July 2026. Input received from this public consultation will be carefully reviewed and will contribute to the refinement and finalization of the document.
For any query related to the consultation, please contact vaccines@who.int with subject " Strep A Vaccine Research and Development Roadmap public consultation".
Comments on the Draft Guidance must be submitted by 11:59pm on Saturday, 4th July 2026, Central European Time (GMT/UHC +1).